Question 1

Who are the top researchers at Celon Pharma (Poland)?

Accepted Answer

Ranked on the quality score, Daria Zdżalik-Bielecka, Filip Mituła and Aleksandra M. Stanczak lead among researchers whose main affiliation is Celon Pharma (Poland).

Question 2

What are the most cited papers from Celon Pharma (Poland)?

Accepted Answer

The most cited paper from Celon Pharma (Poland) is "Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial" (Jonathan M. Spergel, Marc E. Rothenberg, Margaret H. Collins et al., 2011), with 556 citations. Next come "Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer" (81) and "Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma" (78).

Question 3

Which research topics does Celon Pharma (Poland) publish most on?

Accepted Answer

By volume in 2022-now: Phagocytosis and Immune Regulation, Monoclonal and Polyclonal Antibodies Research, Fibroblast Growth Factor Research and Computational Drug Discovery Methods.

Question 4

Which keywords describe research at Celon Pharma (Poland)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Macrophages, Glycosylation, Immune Regulation, Monoclonal Antibodies, apoptotic cells, CD47 and Metabolism.

Question 5

Which fields of science does Celon Pharma (Poland) work in?

Accepted Answer

In 2022-now, 51% of research at Celon Pharma (Poland) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (35%), Medicine (30%), Immunology and Microbiology (10%). It does 2.6× the world's share of Life Sciences.

Question 6

Is Celon Pharma (Poland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 39% higher than in 2018-2021.